Targeted therapies meet AI-driven discovery as these biotech innovators reveal sharply contrasting financials, risk factors, ...

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...

When a stock and the analysts covering it disagree this sharply, one of them is about to be wrong.